Impact of treatment on progression to castration‐resistance, metastases, and death in men with localized high‐grade prostate cancer

Men with high‐grade prostate cancer (HGPC) are at greatest risk of disease progression. Clinical risk factors associated with castration‐resistant prostate cancer (CRPC), metastases, and prostate cancer‐specific mortality (PCSM) were identified in a contemporary HGPC cohort. Clinical data was collec...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Eric T., Chamie, Karim, Kwan, Lorna, Lewis, Michael S., Knudsen, Beatrice S., Garraway, Isla P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269571/
https://www.ncbi.nlm.nih.gov/pubmed/27997745
http://dx.doi.org/10.1002/cam4.981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5269571/
https://www.ncbi.nlm.nih.gov/pubmed/27997745
http://dx.doi.org/10.1002/cam4.981

Ejemplares similares